XRP Healthcare Acquires Pharmacy Chain, Advancing IPO Plans

SPONSORED CONTENT

XRP Healthcare, a pioneering force in  healthcare innovation, has officially acquired  Pharma Ville, a leading retail and wholesale  pharmacy chain in Uganda. This strategic acquisition marks XRP  Healthcare’s entry into Africa’s rapidly  evolving healthcare sector, laying the  foundation for scalable, technology-driven  pharmaceutical distribution across the  continent. With two retail pharmacies and five  wholesale distribution centres strategically  positioned across Uganda, Pharma Ville’s  established infrastructure enhances medicine  accessibility nationwide.  The acquisition strengthens XRP  Healthcare’s ability to streamline  pharmaceutical supply chains and expand its  footprint in Africa’s healthcare market. Shonubi Musoke & Co. Advocates, one of  Uganda’s premier law firms and a partner  of the globally renowned Norton Rose  Fulbright, advised XRP Healthcare in this  transaction,  ensuring a seamless legal and regulatory transition.

Pharma Ville plays a pivotal role in Uganda’s  healthcare sector, working closely with the  National Medical Stores (NMS) and Joint  Medical Stores (JMS) to ensure a steady and  reliable supply of essential medicines. The acquisition includes 60 registered  pharmaceutical products, 18 products ready  for immediate commercialization, and 70  additional products in the pipeline awaiting  regulatory approval. Additionally, Pharma Ville has distribution  agreements with eight global pharmaceutical  suppliers, reinforcing its strong supply chain  network: 

• Toros Group (Switzerland) – Orthopedic 
supplies
XRP Healthcare Acquires Pharmacy Chain, Advancing IPO Plans
• Ascensia Switzerland (Germany) – Diabetic care solutions
• Incepta Pharmaceuticals Ltd (Bangladesh) – Human drugs
• Amanta Health Care Limited (India) – Intravenous fluids
• Forans Latvia (Latvia) – Diabetic care products
• Mediteks (Turkey) – Surgical equipment
• Naari Pharma Pvt Limited (India) – Human drugs
• Universal Corporation Limited (Kenya) – Human drugs

 Founder and CEO of Pharma Ville,  emphasized the transformative impact of this acquisition: “Joining XRP Healthcare is transformative. We can now rapidly  scale our operations, introduce innovative technologies, and  better serve Uganda’s healthcare needs.” Whitney Lynn, Chairman of XRP Healthcare, underscored the  company’s mission: “Our goal is simple—make essential medicines more accessible  and affordable. This acquisition is a major step toward achieving  that.”  Kain Roomes, CEO of XRP Healthcare, highlighted the  opportunity within Uganda’s healthcare sector: “Uganda’s fragmented pharmaceutical  landscape presents immense potential. By  integrating Pharma Ville, we can deliver  immediate impact—improving access to  essential medicines and optimizing healthcare  delivery"

 Laban Roomes, COO of XRP Healthcare,  emphasized the groundwork laid for  expansion: “We have spent significant time in Uganda  developing the legal and operational  frameworks necessary to scale this business  rapidly. Our efforts will drive long-term  improvements in healthcare accessibility.” Pharma Ville will undergo immediate  operational upgrades, including:

• Advanced inventory management to optimize supply chains.
• Upgraded licensing to expand product offerings
• Enhanced distribution channels for wider reach
• Digital payment integration for seamless transactions
• New CRM systems to improve customer engagement

By Q4, Pharma Ville will rebrand as XRP  Healthcare, aligning with the company’s  vision for innovation and healthcare  excellence. The XRPH AI app, a multilingual  healthcare assistant, is already live and  integrated into Pharma Ville’s digital  platform (www.pharmaville.ai). The AIdriven tool provides medical guidance in  Luganda, Swahili, Kinyarwanda, French,  and English. In an upcoming update, users will be able  to upload images of medical conditions for  AI-assisted preliminary assessments, with  direct referrals to healthcare professionals  for critical cases. Peter Waiswa, a strategic advisor to  UNICEF, the Bill & Melinda Gates  Foundation, and now XRP Healthcare,  praised the acquisition’s significance: “This acquisition strengthens Uganda’s  healthcare sector, fosters economic  growth, and introduces essential  technologies to the industry. It’s a major  step forward for healthcare accessibility  in Uganda.” With Africa’s healthcare market projected  to reach $259 billion by 2030, and the  digital health segment—encompassing  AI-driven solutions—expected to grow  to $16.6 billion, XRP Healthcare is  strategically positioned to capitalize on  these transformative opportunities.

XRP Healthcare holds registered  trademarks in Uganda, the UAE, the UK,  and 27 EU countries, with global filings  in progress—reinforcing its commitment  to brand protection and international  expansion. To support its growth trajectory, the  company has brought forward its IPO from 2027 to the third quarter of 2025 on a  Canadian stock exchange—an accelerated  timeline that aims to unlock new  investment opportunities, drive expansion,  and solidify XRP Healthcare’s position as  a global leader in healthcare innovation.

Left to right: Kain Roomes, CEO of XRP Healthcare, and Richard Kitonsa, CEO of Pharma Ville Pharmacy Ltd, during the signing of the acquisition agreement at Shonubi, Musoke & Co. Advocates

About XRP Healthcare XRP Healthcare is a pioneering  AI and M&A-focused healthcare  company dedicated to consolidating and  modernizing healthcare systems across  emerging markets, starting in Africa.  Through acquisitions, digital innovation,  and strategic partnerships, XRP Healthcare  delivers accessible, high-quality medical  solutions that create long-term impact and  scalable returns.